Do you or someone you love have questions about filing a Xarelto lawsuit? If you have suffered injury or the tragic death of a loved one because of complications resulting from the use of blood thinning drug Xarelto, the product liability attorneys at Edelman, Krasin & Jaye are ready to fight for your right to full and just compensation, and to hold the drug’s manufacturers and distributors accountable for their negligence. Our expert Xarelto lawyers have decades of experience filing dangerous drug lawsuits nationwide.
At Edelman, Krasin & Jaye, we are prepared to go to battle for you, whether it’s in settlement talks or waging war in court. We have a full team of investigators and medical experts who can testify on your behalf. We are currently offering free case reviews to victims of Xarelto complications, including irreversible internal bleeding. Call us today at 1.800.469.7429 for a thorough and confidential case evaluation with a personal injury lawyer you can trust.
Why do people take Xarelto?
Xarelto sales skyrocketed 240 percent in the first half of 2013. The oral drug was developed by Bayer and Johnson & Johnson’s New Jersey subsidiary, Janssen Pharmaceuticals, as a blood thinner which prevents dangerous blood clots and obstruction of blood flow to vital organs. According to the Reuters news agency, there were 958 cases of adverse side effects and at least 72 deaths reported to Germany’s Federal Institute for Drugs and Medical Devices in the first eight months of 2013.
The arrival of new blood thinners such as Xarelto, Eliquis, and Pradaxa seemed like a big win for patients. Older anticoagulants like warfarin were a hassle to patients because they involved close blood monitoring from a doctor, changes in diet to limit foods and beverages containing vitamin K, cessation of smoking, and avoiding contact sports.
The FDA approved Xarelto for use in:
- Patients who have had knee or hip replacement surgery to reduce the risk of clotting and stroke.
- Patients with deep vein thrombosis and pulmonary embolism.
- Patients at risk for stroke, recurrent deep vein thrombosis, or pulmonary embolism.
FDA expresses skepticism about the use of Xarelto in some patients
In 2013, the European Medicines Agency approved its use for acute coronary syndrome (ACS), which explains some of the recent fast-track growth. However, in 2011 and again in 2014, U.S. FDA advisors resoundingly voted against approving Xarelto for ACS patients, stating that the data “wasn’t robust enough” and that the “the benefits at this point are outweighed by the risk.”
The FDA’s review of Xarelto side effects has not been thorough, but this latest news suggests that it could be rough going for the company to expand the drug’s use in America.
The FDA has, so far, approved of two serious “black box” warnings on the Xarelto label – one stating that atrial fibrillation patients who stop the drug are at increased risk of fatal blood clots and strokes, and another that patients undergoing spinal taps or epidurals while using the drug could wind up paralyzed.
Dangers of taking Xarelto
There are risks involved in taking new anticoagulants like Xarelto. Severe uncontrolled bleeding episodes are the focus of rapidly escalating nationwide Xarelto lawsuits. When bleeding occurs near the brain, lungs or kidneys, all blood flow to the organ becomes interrupted, causing a total loss of function that usually results in death.
In other cases, uncontrolled bleeding and pools of blood in the body causes serious symptoms such as:
- Abnormal liver function
- Eye hemorrhaging
- Gastrointestinal upset
- Low blood pressure
- Muscle pain
- Nose bleeds
- Rapid heartbeat
- Rectal bleeding
- Reduced platelet levels
There is no known antidote for Xarelto
“What really compounds the matter is the lack of a specific antidote to reverse life-threatening bleeding” from Xarelto, Dr. Sanjay Kaul, a cardiologist at Cedars-Sinai Medical Center in Los Angeles, told the Huffington Post. By contrast, older anti-clotting drugs like Coumadin (warfarin) can be flushed out of the system through dialysis or immediately neutralized using a provided antidote. However, no known antidote exists for drugs like Pradaxa or Xarelto.
Boehringer Ingelheim said they are “working on an antidote,” and J&J said they are “monitoring early efforts by other drugmakers to come up with one.”
Due to insufficient labeling, Dr. Kaul found that many doctors did not test patient kidney function before prescribing these drugs. Eighty percent of the drug is excreted by the kidneys, which means that a weak organ can cause uncontrolled bleeding when there are unsafe blood levels of the drug in the body. Patients with a history of gastrointestinal bleeding are also at increased risk of complications when taking Xarelto or Pradaxa, but doctors failed to ask patients about that as well.
As a result of these failings, lawyers at Edelman, Krasin & Jaye have consulted with many family members who have lost a loved one due to uncontrolled bleeding, and are considering filing a Xarelto lawsuit to seek compensation for wrongful death.
Xarelto bleeding lawsuits expected to balloon this year
As Xarelto lawsuits continue to grow in number, we can look at how events are progressing with Boehringer Ingelheim’s Pradaxa, which is in the same class of new anticoagulants. As of July 2014, more than 2,400 lawsuits were consolidated into MDL 2385 in the federal district court of Illinois, charging that Pradaxa caused uncontrolled bleeding events and deaths in patients. In May, the company announced that it would pay out $650 million to settle at least 4,000 state and federal lawsuits.
Why file a Xarelto lawsuit?
Xarelto lawsuits may be filed by patients harmed by the drug or by surviving family members of patients who suffered the blood thinner’s fatal consequences. Lawyers at Edelman, Krasin & Jaye understand the particulars of laws relating to dangerous drugs, and can guide you every step of the way through the product liability litigation process.
Victims of uncontrolled Xarelto bleeding may be entitled to compensation for:
- Past, present and future medical bills
- Lost wages and loss of earning potential
- Emotional pain and suffering
- Loss of consortium and companionship
- Funeral expenses and survivors’ benefit
Xarelto attorneys must be able to prove that:
- You or someone you love was, in fact, harmed by use of the drug
- The drug was used as recommended by a physician
- You and your doctor were unaware of the risks at the time the drug was prescribed
- No other pre-existing conditions could have caused the uncontrolled bleeding
- The manufacturer knew or should have known of the risks involved with their product
Get a Xarelto attorney who understands your plight
Xarelto lawyers from Edelman, Krasin & Jaye will not only help you by filing all the necessary paperwork with the courts, but will also be there every step of the way so you know when to expect a resolution of your case. Waiting is often the hardest part, as big pharma lawsuits can take a year or more to settle; it helps to have a compassionate, well-informed friend fighting with you side by side.
Heavy duty resources are needed in order to win against well-heeled defendants like Bayer and J&J. Best of all, you only pay a modest legal fee if your Xarelto lawsuit results in a settlement or favorable jury verdict. Call 1-800-469-7429 to discuss your case with a Xarelto attorney, free of charge.
- QualityOfLife.org – Warfarin http://www.qualityoflife.org/tasks/sites/memorialcms/assets/File/anticoag/Warfarin%20FAQs.pdf
- ISMP – Quarter Watch http://www.ismp.org/QuarterWatch/pdfs/2013Q1.pdf
- Reuters - Reports of side-effects from Bayer's Xarelto grow: Spiegel, http://www.reuters.com/article/2013/09/08/us-bayer-xarelto-idUSBRE9870AH20130908
- Huffington Post - Pradaxa And Xarelto: Top Heart Doctors Concerned Over New Blood Thinners http://www.huffingtonpost.com/2012/06/14/pradaxa-xarelto-blood-thinner-doctors-heart_n_1595971.html
- Medscape - Again, FDA Advisors Deliver Solid "No" to Rivaroxaban in ACS http://www.medscape.com/viewarticle/819318
- Reuters - Bayer faces law suits in United States over Xarelto: paper, http://www.reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614
- Lawsuit360.com - J&J Blood Thinner Xarelto Caused Bleeding, Suit Says, http://www.law360.com/articles/511660/j-j-blood-thinner-xarelto-caused-bleeding-suit-says
- JPML – Pending Dockets http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-August-15-2014.pdf
- Xarelto – About Xarelto http://www.xareltohcp.com/about-xarelto/about-xarelto.html